A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane

ABSTRACT Spontaneous hypercortisolism (HC), a prevalent endocrinopathy among elderly dogs, is mainly confirmed by the low dexamethasone dose suppression test (LDDST). However, its diagnostic sensitivity in Brazil is anecdotally reported low compared with published literature. Medical treatment with...

Full description

Saved in:
Bibliographic Details
Main Authors: M.M. Marçal, S.F.M. Martins, C.R. Barbieri, T.B. Nogueira, Á.G. Pöppl
Format: Article
Language:English
Published: Universidade Federal de Minas Gerais 2025-07-01
Series:Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352025000400101&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318723974856704
author M.M. Marçal
S.F.M. Martins
C.R. Barbieri
T.B. Nogueira
Á.G. Pöppl
author_facet M.M. Marçal
S.F.M. Martins
C.R. Barbieri
T.B. Nogueira
Á.G. Pöppl
author_sort M.M. Marçal
collection DOAJ
description ABSTRACT Spontaneous hypercortisolism (HC), a prevalent endocrinopathy among elderly dogs, is mainly confirmed by the low dexamethasone dose suppression test (LDDST). However, its diagnostic sensitivity in Brazil is anecdotally reported low compared with published literature. Medical treatment with mitotane was the rule over decades in Brazil but has been progressively substituted by trilostane, an argued safer drug. This work evaluated the LDDST sensitivity and medical treatment efficacy of trilostane and mitotane in dogs treated for HC in Southern Brazil. The retrospective cohort study included 122 dogs treated with trilostane (58.2%) or mitotane (41.8%). Pituitary-dependent HC cases were overrepresented (81.96%). Treatment outcomes (P=0.61) and survival (P=0.16) were similar in response to mitotane or trilostane, with good clinical control achieved in 72.5% and 62.4% of dogs respectively. The LDDST sensitivity in this population was considered lower (77.8%) than reported in the literature with a cutoff of 1.4 µg/dL for 8-hour post-dexamethasone cortisol; however, a suggested 0.8µg/dL cutoff significantly (P=0.01) increased the test sensitivity to 85.2%. Mitotane should still be considered as a medical treatment option for canine HC. Individually reducing the LDDST cutoff in patients with well-documented clinical Cushing´s syndrome diagnosis could be worthwhile.
format Article
id doaj-art-75e19477aeb74728aa96ba121c13f88f
institution Kabale University
issn 1678-4162
language English
publishDate 2025-07-01
publisher Universidade Federal de Minas Gerais
record_format Article
series Arquivo Brasileiro de Medicina Veterinária e Zootecnia
spelling doaj-art-75e19477aeb74728aa96ba121c13f88f2025-08-20T03:50:45ZengUniversidade Federal de Minas GeraisArquivo Brasileiro de Medicina Veterinária e Zootecnia1678-41622025-07-0177410.1590/1678-4162-13332A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostaneM.M. Marçalhttps://orcid.org/0000-0002-7105-6189S.F.M. Martinshttps://orcid.org/0000-0002-1489-8216C.R. Barbierihttps://orcid.org/0000-0002-6384-1398T.B. Nogueirahttps://orcid.org/0009-0000-3289-0157Á.G. Pöpplhttps://orcid.org/0000-0002-7117-5284ABSTRACT Spontaneous hypercortisolism (HC), a prevalent endocrinopathy among elderly dogs, is mainly confirmed by the low dexamethasone dose suppression test (LDDST). However, its diagnostic sensitivity in Brazil is anecdotally reported low compared with published literature. Medical treatment with mitotane was the rule over decades in Brazil but has been progressively substituted by trilostane, an argued safer drug. This work evaluated the LDDST sensitivity and medical treatment efficacy of trilostane and mitotane in dogs treated for HC in Southern Brazil. The retrospective cohort study included 122 dogs treated with trilostane (58.2%) or mitotane (41.8%). Pituitary-dependent HC cases were overrepresented (81.96%). Treatment outcomes (P=0.61) and survival (P=0.16) were similar in response to mitotane or trilostane, with good clinical control achieved in 72.5% and 62.4% of dogs respectively. The LDDST sensitivity in this population was considered lower (77.8%) than reported in the literature with a cutoff of 1.4 µg/dL for 8-hour post-dexamethasone cortisol; however, a suggested 0.8µg/dL cutoff significantly (P=0.01) increased the test sensitivity to 85.2%. Mitotane should still be considered as a medical treatment option for canine HC. Individually reducing the LDDST cutoff in patients with well-documented clinical Cushing´s syndrome diagnosis could be worthwhile.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352025000400101&lng=en&tlng=enCushing´s syndromehyperadrenocorticismdiagnostic testfalse-negativesurvival
spellingShingle M.M. Marçal
S.F.M. Martins
C.R. Barbieri
T.B. Nogueira
Á.G. Pöppl
A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Cushing´s syndrome
hyperadrenocorticism
diagnostic test
false-negative
survival
title A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
title_full A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
title_fullStr A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
title_full_unstemmed A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
title_short A retrospective cohort study of 122 dogs treated for hypercortisolism: low-dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
title_sort retrospective cohort study of 122 dogs treated for hypercortisolism low dose dexamethasone suppression test sensitivity and comparative outcomes in response to mitotane or trilostane
topic Cushing´s syndrome
hyperadrenocorticism
diagnostic test
false-negative
survival
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352025000400101&lng=en&tlng=en
work_keys_str_mv AT mmmarcal aretrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT sfmmartins aretrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT crbarbieri aretrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT tbnogueira aretrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT agpoppl aretrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT mmmarcal retrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT sfmmartins retrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT crbarbieri retrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT tbnogueira retrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane
AT agpoppl retrospectivecohortstudyof122dogstreatedforhypercortisolismlowdosedexamethasonesuppressiontestsensitivityandcomparativeoutcomesinresponsetomitotaneortrilostane